Tapewire

Nasdaq · USD

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3132
SEC CIK
0001178670
Parsed reports
483

Last 12 months

Inside the activity.

0 purchase rows · 279 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025031
Dec 202500
Jan 20260111
Feb 2026011
Mar 20260106
Apr 2026014
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 12, 2021 Filed Nov 12, 2021 22:52 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionCommon Stock 33,978 $7.10 $241,243.80
Disclosure

SEC source: 0001735276-21-000089 · edgardoc.xml · nonDerivative · entry 1

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,978 options exercised and sold by the reporting person were due to expire on November 30, 2021.

Read SEC document
October 27, 2021 Filed Oct 29, 2021 20:07 UTC GrantStock Option (right to buy) · Derivative 1,814 $0.00 Strike: $191.16 $0.00
Disclosure

SEC source: 0001735276-21-000086 · edgardoc.xml · derivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,814

Underlying: Common Stock · 1,814 shares

Expires 2031-10-26

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 33,979 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · derivative · entry 8

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,978

Underlying: Common Stock · 33,979 shares

Expires 2021-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F7 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 214 $201.55 $43,131.70
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 6

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,765

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 3,828 $200.84 $768,815.52
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 5

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,979

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F5 · price: Sale prices ranged from $200.48 to $201.43.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 23,336 $199.92 $4,665,333.12
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 4

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,807

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F4 · price: Sale prices ranged from $199.46 to $200.45.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 4,160 $198.93 $827,548.80
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 3

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,143

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F3 · price: Sale prices ranged from $198.45 to $199.44.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 2,441 $198.02 $483,366.82
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 2

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,303

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F2 · price: Sale prices ranged from $197.44 to $198.44.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 20:38 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionCommon Stock 33,979 $7.10 $241,250.90
Disclosure

SEC source: 0001735276-21-000083 · edgardoc.xml · nonDerivative · entry 1

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:10 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionPerformance Stock Option 2013 (right to buy) · Derivative 10,834 $0.00 Strike: $63.00 $0.00
Disclosure

SEC source: 0001735276-21-000081 · edgardoc.xml · derivative · entry 4

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,832

Underlying: Common Stock · 10,834 shares

Expires 2023-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:10 UTC
Vaishnaw AkshayPresident, R&D
SaleCommon Stock 10,834 $200.00 $2,166,800.00
Disclosure

SEC source: 0001735276-21-000081 · edgardoc.xml · nonDerivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,215

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 20:10 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionCommon Stock 10,834 $63.00 $682,542.00
Disclosure

SEC source: 0001735276-21-000081 · edgardoc.xml · nonDerivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 20:09 UTC
Greenstreet YvonnePresident & COO
Exercise / conversionStock Option (right to buy) · Derivative 28,064 $0.00 Strike: $77.10 $0.00
Disclosure

SEC source: 0001735276-21-000078 · edgardoc.xml · derivative · entry 6

Greenstreet Yvonne · CIK 0001446125 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,064 shares

Expires 2026-09-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 20:09 UTC
Greenstreet YvonnePresident & COO
Exercise / conversionPerformance Stock Option 2016 (right to buy) · Derivative 25,000 $0.00 Strike: $77.10 $0.00
Disclosure

SEC source: 0001735276-21-000078 · edgardoc.xml · derivative · entry 5

Greenstreet Yvonne · CIK 0001446125 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2026-09-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 20:09 UTC
Greenstreet YvonnePresident & COO
SaleCommon Stock 53,064 $199.00 $10,559,736.00
Disclosure

SEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 3

Greenstreet Yvonne · CIK 0001446125 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,023

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 20:09 UTC
Greenstreet YvonnePresident & COO
Exercise / conversionCommon Stock 25,000 $77.10 $1,927,500.00
Disclosure

SEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,087

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.

Read SEC document
August 06, 2021 Filed Aug 9, 2021 20:09 UTC
Greenstreet YvonnePresident & COO
Exercise / conversionCommon Stock 28,064 $77.10 $2,163,734.40
Disclosure

SEC source: 0001735276-21-000078 · edgardoc.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,087

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 20:09 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,876 $0.00 Strike: $88.95 $0.00
Disclosure

SEC source: 0001735276-21-000079 · edgardoc.xml · derivative · entry 6

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,124

Underlying: Common Stock · 7,876 shares

Expires 2025-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 20:09 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionPerformance Stock Option 2015 (right to buy) · Derivative 2,124 $0.00 Strike: $88.95 $0.00
Disclosure

SEC source: 0001735276-21-000079 · edgardoc.xml · derivative · entry 5

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,876

Underlying: Common Stock · 2,124 shares

Expires 2025-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 20:09 UTC
KEATING LAURIEEVP, Chief Legal Officer
SaleCommon Stock 10,000 $188.95 $1,889,500.00
Disclosure

SEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 3

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,132

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 20:09 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionCommon Stock 2,124 $88.95 $188,929.80
Disclosure

SEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 2

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 20:09 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionCommon Stock 7,876 $88.95 $700,570.20
Disclosure

SEC source: 0001735276-21-000079 · edgardoc.xml · nonDerivative · entry 1

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 23:31 UTC
BONNEY MICHAEL WDirector · Executive Chair
GrantRestricted Stock Units · Derivative 22,477 $0.00 $0.00
Disclosure

SEC source: 0001735276-21-000075 · edgardoc.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director · Executive Chair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,477

Underlying: Common Stock · 22,477 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.

F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors.

F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of August 2, 2023 and the date the Reporting Person ceases to serve as a director of the Company other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:23 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000073 · edgardoc.xml · derivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:19 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000065 · edgardoc.xml · derivative · entry 1

Fanucci Marsha · CIK 0001298814 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:22 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000072 · edgardoc.xml · derivative · entry 1

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:22 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000071 · edgardoc.xml · derivative · entry 1

HAMBURG MARGARET A · CIK 0001266917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:22 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000070 · edgardoc.xml · derivative · entry 1

Reitan Colleen F · CIK 0001740730 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:21 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000069 · edgardoc.xml · derivative · entry 1

BONNEY MICHAEL W · CIK 0001219016 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:21 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000068 · edgardoc.xml · derivative · entry 1

SCHULMAN AMY W · CIK 0001438226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:20 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000067 · edgardoc.xml · derivative · entry 1

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:20 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000066 · edgardoc.xml · derivative · entry 1

PAUL STEVEN M · CIK 0001237564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 15, 2021 Filed Jul 19, 2021 20:18 UTC GrantStock Option (right to buy) · Derivative 4,032 $0.00 Strike: $171.95 $0.00
Disclosure

SEC source: 0001735276-21-000064 · edgardoc.xml · derivative · entry 1

SHARP PHILLIP A · CIK 0001226295 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,032

Underlying: Common Stock · 4,032 shares

Expires 2031-07-14

F1 · derivative.exercise_date: This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $88.95 $0.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · derivative · entry 7

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 5,000 shares

Expires 2025-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,812 $0.00 Strike: $85.00 $0.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · derivative · entry 6

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,188

Underlying: Common Stock · 1,812 shares

Expires 2029-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
SaleCommon Stock 5,000 $178.95 $894,750.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 4

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,132

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
SaleCommon Stock 1,812 $179.00 $324,348.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 3

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,132

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionCommon Stock 5,000 $88.95 $444,750.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 2

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
July 12, 2021 Filed Jul 14, 2021 20:58 UTC
KEATING LAURIEEVP, Chief Legal Officer
Exercise / conversionCommon Stock 1,812 $85.00 $154,020.00
Disclosure

SEC source: 0001735276-21-000053 · edgardoc.xml · nonDerivative · entry 1

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,944

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionStock Option (right to buy) · Derivative 970 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001735276-21-000051 · edgardoc.xml · derivative · entry 6

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,368

Underlying: Common Stock · 970 shares

Expires 2026-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

F3 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionPerformance Stock Option 2013 (right to buy) · Derivative 10,834 $0.00 Strike: $63.00 $0.00
Disclosure

SEC source: 0001735276-21-000051 · edgardoc.xml · derivative · entry 5

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,666

Underlying: Common Stock · 10,834 shares

Expires 2023-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Vaishnaw AkshayPresident, R&D
SaleCommon Stock 14,708 $175.00 $2,573,900.00
Disclosure

SEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 3

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,215

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionCommon Stock 970 $42.22 $40,953.40
Disclosure

SEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 2

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
June 18, 2021 Filed Jun 22, 2021 20:07 UTC
Vaishnaw AkshayPresident, R&D
Exercise / conversionCommon Stock 10,834 $63.00 $682,542.00
Disclosure

SEC source: 0001735276-21-000051 · edgardoc.xml · nonDerivative · entry 1

Vaishnaw Akshay · CIK 0001458494 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:13 UTC
KEATING LAURIEEVP, Chief Legal Officer
SaleCommon Stock 1,734 $154.00 $267,036.00
Disclosure

SEC source: 0001735276-21-000047 · edgardoc.xml · nonDerivative · entry 1

KEATING LAURIE · CIK 0001620743 · EVP, Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,132

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

Read SEC document
May 13, 2021 Filed May 17, 2021 23:25 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
Exercise / conversionStock Option (right to buy) · Derivative 33,979 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001735276-21-000044 · edgardoc.xml · derivative · entry 10

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,957

Underlying: Common Stock · 33,979 shares

Expires 2021-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F10 · derivative.exercise_date: The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Read SEC document
May 13, 2021 Filed May 17, 2021 23:25 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 1,023 $134.37 $137,460.51
Disclosure

SEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 8

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,765

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F8 · price: Sale prices ranged from $134.11 to $134.40.

Read SEC document
May 13, 2021 Filed May 17, 2021 23:25 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 1,624 $133.56 $216,901.44
Disclosure

SEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 7

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,788

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F7 · price: Sale prices ranged from $132.97 to $133.77.

Read SEC document
May 13, 2021 Filed May 17, 2021 23:25 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 3,481 $132.32 $460,605.92
Disclosure

SEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 6

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,412

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F6 · price: Sale prices ranged from $131.84 to $132.78.

Read SEC document
May 13, 2021 Filed May 17, 2021 23:25 UTC
MARAGANORE JOHNDirector · Chief Executive Officer
SaleCommon Stock 11,203 $131.18 $1,469,609.54
Disclosure

SEC source: 0001735276-21-000044 · edgardoc.xml · nonDerivative · entry 5

MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,893

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,979 options exercised and sold by the reporting person were due to expire on November 30, 2021.

F5 · price: Sale prices ranged from $130.82 to $131.81.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.